EUVIMEDEUVIMED entdecken
Crossref

Limited Sampling Strategy for Predicting the Area under Plasma Concentration–Time Curve of Nadolol in Healthy Subjects

Shingen Misaka iD, Yuko Maejima, Kenju Shimomura

The Journal of Clinical Pharmacology · 2025

DOI: 10.1002/jcph.6164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2025. Verfasst von Shingen Misaka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Models, Biological, Nadolol. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nadolol is a hydrophilic β‐adrenoceptor blocker with a relatively long half‐life and negligible metabolism. It is a substrate of P‐glycoprotein and organic anion transporting polypeptide 1A2, and may serve as an in vivo probe drug for the assessment of drug–drug and food–drug interactions mediated by these transporters. In the present study, we aimed to develop limited sampling strategy (LSS) models for predicting the area under the plasma concentration–time curve (AUC 0‐∞ ) of nadolol. Plasma concentration data (C t ) in healthy volunteers reported in four previous studies were randomly divided into a training dataset for model development (n = 15) and a test dataset for model validation (n = 16). By multiple linear regression analysis, we confirmed that four out of the eight models using two time points and all models using three time points met the acceptable criteria. In particular, the three time point models using (C 3 , C 6 , and C 24 ) and (C 4 , C 8 , and C 24 ) showed better predictive performances with r 2 values of 0.983 and 0.980, respectively. In drug interaction studies of nadolol with itraconazole, rifampicin, grapefruit juice, and green tea extract, both LSS models accurately predicted the AUC 0‐∞ with percent mean absolute error ≤11% and percent root mean square error ≤12%. In addition, using digitized pharmacokinetic data of nadolol, both LSS models were further validated by predicting the AUC 0‐∞ in different doses. The results suggest that the LSS models using three time points allow a reliable prediction of AUC 0‐∞ of nadolol in healthy individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-AntagonistsModels, BiologicalNadololAdultFemaleHumansMaleYoung AdultArea Under CurveFood-Drug InteractionsHealthy Volunteers

Stichwörter der Autor:innen

drug interactionlimited sampling strategynadololpharmacokinetics

Substanzen

Adrenergic beta-AntagonistsNadolol

Autor:innen und Institutionen

  • Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.

ORCID-Profile: Shingen Misaka

Zitieren

APA

Misaka, S., Maejima, Y., & Shimomura, K. (2025). Limited Sampling Strategy for Predicting the Area under Plasma Concentration–Time Curve of Nadolol in Healthy Subjects. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.6164

Vancouver

Misaka S, Maejima Y, Shimomura K. Limited Sampling Strategy for Predicting the Area under Plasma Concentration–Time Curve of Nadolol in Healthy Subjects. The Journal of Clinical Pharmacology. 2025. doi:10.1002/jcph.6164

BibTeX
@article{Misaka2025,
  author = {Misaka, Shingen and Maejima, Yuko and Shimomura, Kenju},
  title = {Limited Sampling Strategy for Predicting the Area under Plasma Concentration–Time Curve of Nadolol in Healthy Subjects},
  journal = {The Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/jcph.6164}
}
Kostenlos starten →